A promising medium ‐term follow‐up of pediatric sclerosing cholangitis: Mild phenotype or early diagnosis?
ConclusionsIn our early diagnosed cohort, the 9‐year survival with native liver was better than that reported in other studies. Approximately 15% of patients developed liver‐related disease complications, less than previously reported. The long‐term course of SC was negatively influenced by the presence of autoimmune features, but not by concomitant IBD.
Source: Hepatology Research - Category: Internal Medicine Authors: Federica Ferrari, Giusy Ranucci, Marina Aloi, Luca Della Volpe, Franca Viola, Erasmo Miele, Salvatore Cucchiara, Raffaele Iorio Tags: Original Article Source Type: research
More News: Autoimmune Disease | Children | Cirrhosis | Hepatitis | Inflammatory Bowel Disease | Internal Medicine | Liver | Liver Disease | Liver Transplant | Pediatrics | Study | Transplants | Urology & Nephrology